bioAffinity Technologies, Inc.
BIAF
$0.245
$0.0062.51%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -31.51% | -16.04% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -31.51% | -16.04% | |||
| Cost of Revenue | -25.68% | -12.44% | |||
| Gross Profit | -47.93% | -24.74% | |||
| SG&A Expenses | -9.70% | -16.02% | |||
| Depreciation & Amortization | -26.78% | 0.65% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.53% | -13.07% | |||
| Operating Income | 4.24% | 10.84% | |||
| Income Before Tax | -52.05% | 10.62% | |||
| Income Tax Expenses | 233.33% | -- | |||
| Earnings from Continuing Operations | -52.64% | 10.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -52.64% | 10.33% | |||
| EBIT | 4.24% | 10.84% | |||
| EBITDA | 10.23% | 8.02% | |||
| EPS Basic | -3.30% | 18.44% | |||
| Normalized Basic EPS | -2.94% | 18.74% | |||
| EPS Diluted | -3.30% | 18.44% | |||
| Normalized Diluted EPS | -2.94% | 18.74% | |||
| Average Basic Shares Outstanding | 47.76% | 9.94% | |||
| Average Diluted Shares Outstanding | 47.76% | 9.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||